📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: AGC Biologics

1.1 - Company Overview

AGC Biologics Logo

AGC Biologics

Headquarter: Denmark
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical contract development and manufacturing services, including microbial fermentation and mammalian cell culture cGMP manufacturing, process development and scale-up, and production of biopharmaceuticals for pre-clinical, clinical, and market supply. Offers CDMO services for biologics and ATMPs, AGCellerate (DNA-to-IND), lentiviral and AAV vector production, and ADC development and manufacturing.

Products and services

  • AGCellerate: Delivers support for drug substance development, specifically supporting the transition from DNA to Investigational New Drug (IND) (IND-enabling)
  • Bioprocess Manufacturing: Produces biologics and ATMPs via microbial fermentation and mammalian cell culture, enabling process development, protein process scale-up, and production for pre-clinical, clinical, and market supply under cGMP (cGMP-compliant)
  • Contract Development Manufacturing (CDMO) Services: Supplies comprehensive contract development and manufacturing for biologics and cell & gene therapies, executing process development, protein process scale-up, and cGMP production for pre-clinical, clinical trials, and market supply (cGMP-compliant)

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to AGC Biologics

AustinPx Logo

AustinPx

HQ: United States Website
  • Description: Provider of formulation and processing technologies for drug manufacturing, offering KinetiSol Technology for amorphous solid dispersions, bioavailability enhancement via amorphous dispersions, particle size reduction and lipid delivery, dosage form development, rapid screening, phase-appropriate analytics, and oral drug product manufacturing for preclinical through Phase II.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AustinPx company profile →
Alliance Pharma Logo

Alliance Pharma

HQ: United Kingdom Website
  • Description: Provider of healthcare solutions through the acquisition and licensing of mature pharmaceutical products, with manufacturing, storage, logistics, and sales operations controlled by Alliance and outsourced to leading specialist organisations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alliance Pharma company profile →
Cellumen Logo

Cellumen

HQ: United States Website
  • Description: Provider of cellular systems biology solutions delivering accurate predictions of drug efficacy and safety to drive Discovery Toxicology and reduce failure rates and development costs. Offers biomarker analysis tools, including for COVID-19 and cardiac issues, cloning, assay kits (ELISA and protein), and cDNA for research.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cellumen company profile →
EAG Laboratories Logo

EAG Laboratories

HQ: United States Website
  • Description: Provider of global scientific services across technology-related industries, offering materials testing & analysis; advanced microscopy (SEM, TEM, STEM); chemical analysis; battery materials analysis; biomedical analysis; and compositional analysis & material identification. Through multidisciplinary expertise in life, materials and engineering sciences, helps companies innovate and improve products, ensure quality and safety, and protect intellectual property.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EAG Laboratories company profile →
Girindus Logo

Girindus

HQ: Germany Website
  • Description: Provider of solid-phase oligonucleotide manufacturing and customer-driven services for pharmaceutical clients, including process development, analytical method development, radiolabeling, cGMP-compliant scale-up, active ingredient manufacturing, and regulatory support, with expertise in both oligonucleotide and small molecule.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Girindus company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for AGC Biologics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to AGC Biologics

2.2 - Growth funds investing in similar companies to AGC Biologics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for AGC Biologics

4.2 - Public trading comparable groups for AGC Biologics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to AGC Biologics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About AGC Biologics

What does AGC Biologics do?

AGC Biologics is a provider of biopharmaceutical contract development and manufacturing services, including microbial fermentation and mammalian cell culture cGMP manufacturing, process development and scale-up, and production of biopharmaceuticals for pre-clinical, clinical, and market supply. Offers CDMO services for biologics and ATMPs, AGCellerate (DNA-to-IND), lentiviral and AAV vector production, and ADC development and manufacturing.

Who are AGC Biologics's competitors?

AGC Biologics's competitors and similar companies include AustinPx, Alliance Pharma, Cellumen, EAG Laboratories, and Girindus.

Where is AGC Biologics headquartered?

AGC Biologics is headquartered in Denmark.

How many employees does AGC Biologics have?

AGC Biologics has 1,000 employees 🔒.

When was AGC Biologics founded?

AGC Biologics was founded in 2010 🔒.

What sector and industry vertical is AGC Biologics in?

AGC Biologics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for AGC Biologics

Who are the top strategic acquirers in AGC Biologics's sector and industry

Top strategic M&A buyers and acquirers in AGC Biologics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for AGC Biologics?

Top strategic M&A buyers groups and sectors for AGC Biologics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in AGC Biologics's sector and industry vertical

Which are the top PE firms investing in AGC Biologics's sector and industry vertical?

Top PE firms investing in AGC Biologics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in AGC Biologics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in AGC Biologics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in AGC Biologics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to AGC Biologics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in AGC Biologics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for AGC Biologics?

The key public trading comparables and valuation benchmarks for AGC Biologics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for AGC Biologics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for AGC Biologics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in AGC Biologics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for AGC Biologics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in AGC Biologics's' sector and industry vertical?

Access recent funding rounds and capital raises in AGC Biologics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for AGC Biologics

Launch login modal Launch register modal